VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ANVS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ANVSAnnovis Bio, Inc.
$1.92$38M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksANVSQuarterly Financials

Annovis Bio, Inc. (ANVS) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Annovis Bio, Inc. (ANVS) quarterly income statement — complete revenue, gross profit & net income history

ANVS Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold00000000000000000000
COGS % of Revenue--------------------
Gross Profit00000000000000000000
Gross Margin %--------------------
Gross Profit Growth %--------------------
Operating Expenses18.01M9.71M7.43M6.27M6.28M6.73M4.39M7.76M7.81M10.44M14.86M9.76M9.97M7.8M6.48M5.97M-5.25M5.92M2.85M2.53M
OpEx % of Revenue--------------------
Selling, General & Admin1.29B955.15K1.14M1.11M1.27M1.74M1.7M1.98M1.29M1.54M1.03M1.5M2.18M1.59M2.36M1.94M3.1M3.04M1.47M709.65K
SG&A % of Revenue--------------------
Research & Development16.72B8.75M6.29M5.16M5.01M5M2.69M5.79M6.51M8.9M13.84M8.26M7.79M6.21M4.12M4.03M2.15M2.88M1.38M1.82M
R&D % of Revenue--------------------
Other Operating Expenses-1000K000000000000000-1000K000
Operating Income-18.01M-9.71M-7.43M-6.27M-6.28M-6.73M-4.39M-7.76M-7.81M-10.44M-14.86M-9.76M-9.97M-7.8M-6.48M-5.97M5.25M-5.92M-2.85M-2.53M
Operating Margin %--------------------
Operating Income Growth %-186.7%-44.12%-69.45%19.21%19.55%35.5%70.48%20.46%21.66%-33.87%-129.2%-63.41%-289.77%-31.76%-127.24%-135.68%262.69%-210.01%-77.94%0.37%
EBITDA-18.01M-9.71M-7.43M-6.27M-6.28M-6.73M-4.39M-7.76M-7.81M-22.21M-14.86M-9.76M-9.97M0-6.48M-5.97M-5.25M0-2.85M-2.53M
EBITDA Margin %--------------------
EBITDA Growth %-186.7%-44.12%-69.45%19.21%19.55%69.68%70.48%20.46%21.66%--129.2%-63.41%-89.77%--127.24%-136.37%-64.19%--180.65%-8.19%
D&A (Non-Cash Add-back)0003121-2000007.8M0005.92M00
EBIT-18.01M-9.71M-7.43M-6.27M-6.28M-6.73M-4.39M-7.76M-7.81M-22.21M-14.86M-9.76M-9.97M-7.8M-6.48M-5.97M-5.25M-5.92M-2.85M-2.53M
Net Interest Income137.8K167.74K152.32K191.4K187.61K126.27K-389K-1.32M44.17K66.13K146.66K222.58K232.53K74.15K52.89K36.02K19.65K5.45K5.55K2.13K
Interest Income137.8K167.74K152.32K191.4K187.61K126.27K135.43K25.98K44.17K66.13K146.66K222.58K232.53K74.15K52.89K36.02K19.65K5.45K5.55K2.13K
Interest Expense000000524.07K1.35M000000000000
Other Income/Expense405.8K-128.26K172.32K51.4K745.61K870.21K-8.25M2.74M6.74M-11.77M146.66K222.58K232.53K74.15K52.89K36.02K-10.49M5.45K5.55K9.55K
Pretax Income-17.61M-9.83M-7.26M-6.22M-5.54M-5.86M-12.64M-5.02M-1.07M-22.21M-14.72M-9.54M-9.74M-7.73M-6.43M-5.94M-5.23M-5.91M-2.85M-2.52M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-17.61M-9.83M-7.26M-6.22M-5.54M-5.86M-12.64M-5.02M-1.07M-22.21M-14.72M-9.54M-9.74M-7.73M-6.43M-5.94M-5.23M-5.91M-2.85M-2.52M
Net Margin %--------------------
Net Income Growth %-217.97%-67.69%42.53%-23.9%-418.96%73.6%14.12%47.36%89.04%-187.51%-128.8%-60.66%-86.03%-30.63%-125.82%-135.14%-63.58%-246.98%-183.02%-9.31%
Net Income (Continuing)-17.61M-9.83M-7.26M-6.22M-5.54M-5.86M-12.64M-5.02M-1.07M-22.21M-14.72M-9.54M-9.74M-7.73M-6.43M-5.94M-5.23M-5.91M-2.85M-2.52M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.63-0.40-0.37-0.32-0.45-0.48-0.97-0.44-0.10-2.33-1.63-1.07-3.59-0.37-0.92-1.06-0.72-0.73-0.35-0.34
EPS Growth %-40%16.67%61.86%27.27%-350%79.4%40.49%58.88%97.21%-529.73%-77.17%-0.94%-398.61%49.32%-162.86%-211.76%-56.52%-192%-133.33%0%
EPS (Basic)-0.63-0.40-0.37-0.32-0.32-0.43-0.97-0.44-0.10-2.33-1.63-1.07-3.59-0.37-0.79-1.06-0.72-0.73-0.35-0.34
Diluted Shares Outstanding27.85M24.81M19.69M19.49M12.23M13.79M12.98M11.31M10.63M9.53M9.01M8.95M8.2M8.16M8.16M8.16M8.16M8.1M8.1M7.37M
Basic Shares Outstanding27.85M24.81M19.69M19.49M12.18M13.79M12.98M11.31M10.63M9.53M9.01M8.95M8.2M8.16M8.16M8.16M8.16M8.1M8.1M7.37M
Dividend Payout Ratio--------------------